• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

日本五种主要癌症的第一年医疗资源利用成本。

First-Year Healthcare Resource Utilization Costs of Five Major Cancers in Japan.

机构信息

Division of Health Services Research, National Cancer Center, Tokyo 104-0045, Japan.

Department of Social Medicine, Graduate School of Medicine, University of Tokyo, Tokyo 113-8654, Japan.

出版信息

Int J Environ Res Public Health. 2021 Sep 7;18(18):9447. doi: 10.3390/ijerph18189447.

DOI:10.3390/ijerph18189447
PMID:34574371
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8466127/
Abstract

Reports on the expenditure of cancer treatments per patient using comprehensive data remain unavailable in Japan. This study aimed to use Japan's cancer registry data and health service utilization data for evaluating the disease-specific, per-patient costs of five major cancers-stomach, lung, colorectal, liver, and breast cancers. We used a database linking the 2017 data from a hospital-based cancer registry and the health service utilization data from the Diagnosis Procedure Combination survey. All patients who started their first treatment course at each hospital were included. The costs were calculated using the total volume of the health services provided and the unit fee information included in the data. We analyzed 304,698 patients. Lung cancer had the highest healthcare cost per-patient for the first year of diagnosis and the longest median hospitalization duration. Conversely, breast cancer showed the lowest cost and the shortest median hospitalization duration. However, in the first month after diagnosis, colorectal cancer showed the highest cost. Subsequently, the gaps between the costs of the five common cancers drastically diminished. The cancer type having the longest hospitalization duration had the highest overall healthcare resource utilization costs. This information is essential for care planning and research studies.

摘要

在日本,仍缺乏关于每位癌症患者治疗支出的报告。本研究旨在使用日本癌症登记数据和卫生服务利用数据,评估五种主要癌症(胃癌、肺癌、结直肠癌、肝癌和乳腺癌)的特定疾病、每位患者的成本。我们使用了一个数据库,将 2017 年医院癌症登记处的数据和诊断程序组合调查中的卫生服务利用数据进行了链接。所有在每家医院开始首个治疗疗程的患者均被纳入分析。成本是根据提供的卫生服务总量和数据中包含的单位费用信息计算得出的。我们分析了 304698 名患者。肺癌在诊断后第一年的每位患者的医疗保健费用最高,中位住院时间最长。相反,乳腺癌的成本最低,中位住院时间最短。然而,在诊断后的第一个月,结直肠癌的成本最高。随后,五种常见癌症的成本差距急剧缩小。住院时间最长的癌症类型具有最高的整体医疗资源利用成本。这些信息对于护理计划和研究很重要。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9821/8466127/9d3e4badb9b7/ijerph-18-09447-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9821/8466127/c510ed33b12f/ijerph-18-09447-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9821/8466127/9d3e4badb9b7/ijerph-18-09447-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9821/8466127/c510ed33b12f/ijerph-18-09447-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9821/8466127/9d3e4badb9b7/ijerph-18-09447-g002.jpg

相似文献

1
First-Year Healthcare Resource Utilization Costs of Five Major Cancers in Japan.日本五种主要癌症的第一年医疗资源利用成本。
Int J Environ Res Public Health. 2021 Sep 7;18(18):9447. doi: 10.3390/ijerph18189447.
2
Direct costs of both inpatient and outpatient care for all type cancers: The evidence from Beijing, China.所有类型癌症的住院和门诊治疗的直接费用:来自中国北京的证据。
Cancer Med. 2019 Jun;8(6):3250-3260. doi: 10.1002/cam4.2184. Epub 2019 May 7.
3
Potentially inappropriate medication use and associated healthcare utilization and costs among older adults with colorectal, breast, and prostate cancers.老年结直肠癌、乳腺癌和前列腺癌患者潜在不适当药物使用与相关医疗保健利用和费用。
J Geriatr Oncol. 2019 Sep;10(5):698-704. doi: 10.1016/j.jgo.2019.01.012. Epub 2019 Feb 13.
4
Costs associated with febrile neutropenia in the US.美国发热性中性粒细胞减少症相关成本。
Pharmacoeconomics. 2012 Sep 1;30(9):809-23. doi: 10.2165/11592980-000000000-00000.
5
The disease burden of mucormycosis in Japan: results from a systematic literature review and retrospective database study.日本毛霉菌病的疾病负担:系统文献回顾和回顾性数据库研究的结果。
Curr Med Res Opin. 2021 Feb;37(2):253-260. doi: 10.1080/03007995.2020.1846510. Epub 2020 Nov 18.
6
Fracture risk and healthcare resource utilization and costs among osteoporosis patients with type 2 diabetes mellitus and without diabetes mellitus in Japan: retrospective analysis of a hospital claims database.日本2型糖尿病合并和未合并糖尿病的骨质疏松症患者的骨折风险、医疗资源利用及成本:医院理赔数据库的回顾性分析
BMC Musculoskelet Disord. 2016 Nov 25;17(1):489. doi: 10.1186/s12891-016-1344-9.
7
Impact of metastatic colorectal cancer stage and number of treatment courses on patient health care costs and utilization.转移性结直肠癌分期和治疗疗程数对患者医疗保健费用和利用的影响。
Postgrad Med. 2013 Mar;125(2):73-82. doi: 10.3810/pgm.2013.03.2642.
8
Association between outpatient orthopedic surgery costs and healthcare facility characteristics.门诊骨科手术费用与医疗机构特征之间的关联。
Int J Health Care Qual Assur. 2018 Apr 16;31(3):265-272. doi: 10.1108/IJHCQA-03-2017-0043.
9
National healthcare spending in the U.S. and Japan: national economic policy and implications for neurosurgery.美国和日本的国家医疗支出:国家经济政策及其对神经外科的影响。
Neurol Med Chir (Tokyo). 2005 Jan;45(1):18-24. doi: 10.2176/nmc.45.18.
10
Cost drivers for breast, lung, and colorectal cancer care in a commercially insured population over a 6-month episode: an economic analysis from a health plan perspective.从健康保险计划角度对商业保险人群6个月内乳腺癌、肺癌和结直肠癌护理的成本驱动因素进行的经济分析。
J Med Econ. 2017 Oct;20(10):1018-1023. doi: 10.1080/13696998.2017.1339353. Epub 2017 Jul 3.

引用本文的文献

1
Contributing to a value-based health care framework for lung cancer patients in Switzerland - A methodological approach to merge routinely collected hospital data.为瑞士肺癌患者构建基于价值的医疗保健框架——一种整合常规收集的医院数据的方法。
PLoS One. 2025 Jul 10;20(7):e0327814. doi: 10.1371/journal.pone.0327814. eCollection 2025.
2
Factors Influencing Willingness to Undergo Lung Cancer Screening in the Future: A Cross-Sectional Study of Japanese University Students.影响未来接受肺癌筛查意愿的因素:一项针对日本大学生的横断面研究。
Healthcare (Basel). 2024 Apr 17;12(8):849. doi: 10.3390/healthcare12080849.
3

本文引用的文献

1
Global, Regional, and National Cancer Incidence, Mortality, Years of Life Lost, Years Lived With Disability, and Disability-Adjusted Life-Years for 29 Cancer Groups, 1990 to 2017: A Systematic Analysis for the Global Burden of Disease Study.全球、区域和国家癌症发病率、死亡率、生命损失年数、失能生存年数以及 29 种癌症组别的伤残调整生命年数:1990 至 2017 年全球疾病负担研究的系统分析。
JAMA Oncol. 2019 Dec 1;5(12):1749-1768. doi: 10.1001/jamaoncol.2019.2996.
2
Quality indicators for cervical cancer care in Japan.日本宫颈癌护理质量指标。
J Gynecol Oncol. 2018 Nov;29(6):e83. doi: 10.3802/jgo.2018.29.e83.
3
Health services costs for cancer care in Australia: Estimates from the 45 and Up Study.
Medical care costs according to the stage and subtype of breast cancer in a municipal setting: a case study of Hachioji City, Japan.
在市级环境下,乳腺癌的分期和亚型决定了医疗费用:以日本八王子市为例的一项案例研究。
Breast Cancer. 2024 Jan;31(1):105-115. doi: 10.1007/s12282-023-01517-7. Epub 2023 Nov 20.
4
Cancer treatment-related financial toxicity in Japan: a scoping review.日本癌症治疗相关的经济毒性:一项范围综述
Front Psychol. 2023 Aug 1;14:1205016. doi: 10.3389/fpsyg.2023.1205016. eCollection 2023.
5
Health Care Resource Use Among Patients with Advanced Non-Small Cell Lung Cancer in Japan, 2017-2019.2017 - 2019年日本晚期非小细胞肺癌患者的医疗资源使用情况
Curr Ther Res Clin Exp. 2023 Jul 3;99:100712. doi: 10.1016/j.curtheres.2023.100712. eCollection 2023.
6
Validation of algorithms to identify colorectal cancer patients from administrative claims data of a Japanese hospital.验证算法以从日本医院的行政索赔数据中识别结直肠癌患者。
BMC Health Serv Res. 2023 Mar 21;23(1):274. doi: 10.1186/s12913-023-09266-1.
7
Cancer Survivors' Long-Term Health Service Costs in Queensland, Australia: Results of a Population-Level Data Linkage Study (Cos-Q).澳大利亚昆士兰州癌症幸存者的长期健康服务费用:基于人群水平数据链接研究(Cos-Q)的结果。
Int J Environ Res Public Health. 2022 Aug 2;19(15):9473. doi: 10.3390/ijerph19159473.
8
Effect of WeChat-Based Health Education Combined with Satir Model on Self-Management Behaviors and Social Adaptation in Colorectal Cancer Patients during the Perioperative Period.基于微信的健康教育联合讽刺模型对结直肠癌患者围手术期自我管理行为和社会适应的影响。
J Healthc Eng. 2021 Dec 10;2021:2701039. doi: 10.1155/2021/2701039. eCollection 2021.
澳大利亚癌症护理的卫生服务费用:来自 45 岁及以上研究的估计。
PLoS One. 2018 Jul 30;13(7):e0201552. doi: 10.1371/journal.pone.0201552. eCollection 2018.
4
Development of an Official Guideline for the Economic Evaluation of Drugs/Medical Devices in Japan.日本药品/医疗器械经济评估官方指南的制定。
Value Health. 2017 Mar;20(3):372-378. doi: 10.1016/j.jval.2016.08.726. Epub 2016 Oct 21.
5
Real-world cost analysis of chemotherapy for colorectal cancer in Japan: detailed costs of various regimens during the entire course of chemotherapy.日本结直肠癌化疗的真实世界成本分析:化疗全过程中各种方案的详细成本
BMC Health Serv Res. 2016 Jan 4;16:2. doi: 10.1186/s12913-015-1253-x.
6
Monitoring and evaluating the quality of cancer care in Japan using administrative claims data.利用行政索赔数据监测和评估日本癌症护理质量。
Cancer Sci. 2016 Jan;107(1):68-75. doi: 10.1111/cas.12837. Epub 2015 Nov 30.
7
Patterns of cancer care costs in a country with detailed individual data.一个拥有详细个体数据的国家的癌症治疗费用模式。
Med Care. 2015 Apr;53(4):302-9. doi: 10.1097/MLR.0000000000000330.
8
Economic burden of cancer across the European Union: a population-based cost analysis.欧盟癌症的经济负担:基于人群的成本分析。
Lancet Oncol. 2013 Nov;14(12):1165-74. doi: 10.1016/S1470-2045(13)70442-X. Epub 2013 Oct 14.
9
Cost of illness in colorectal cancer: an international review.结直肠癌的疾病经济负担:国际研究综述。
Pharmacoeconomics. 2013 Jul;31(7):577-88. doi: 10.1007/s40273-013-0055-4.
10
The national database of hospital-based cancer registries: a nationwide infrastructure to support evidence-based cancer care and cancer control policy in Japan.国家医院癌症登记数据库:支持日本循证癌症护理和癌症控制政策的全国性基础设施。
Jpn J Clin Oncol. 2014 Jan;44(1):2-8. doi: 10.1093/jjco/hyt013. Epub 2013 Feb 28.